New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
November 20, 2009
10:36 EDTDNDN
theflyonthewall.com: Dendreon should continue higher as PDUFA nears, says Rodman & Renshaw
Rodman & Renshaw points out that this morning, the FDA informed Dendreon that the company's amended BLA for Provenge has been accepted for review and has been assigned a PDUFA date of May 1, 2010. The firm expects shares to continue to move higher as the PDUFA approaches and reiterates an Outperform rating on the stock. Rodman & Renshaw also believes Dendreon has a potential takeout value of $5.4B, which equates to $46 per share. :theflyonthewall.com



News For DNDN From The Last 14 Days
Check below for free stories on DNDN the last two weeks.
There are 15 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 3, 2012
10:30 EDTDNDN
theflyonthewall.com: On The Fly: Analyst Upgrade Summary

Subscribe for More Information :theflyonthewall.com
06:11 EDTDNDN
theflyonthewall.com: Dendreon upgraded to Neutral from Underperform at BofA/Merrill

Subscribe for More Information :theflyonthewall.com

February 1, 2012
13:08 EDTDNDN
theflyonthewall.com: Dendreon CEO change could lead to restructuring, says Cantor
Cantor believes John Johnson's background in marketing and cost structure could lead to a restructuring within Dendreon in 2012. The firm views the CEO transition to Johnson as a good move for Dendreon but keeps a Hold rating on the stock. :theflyonthewall.com
09:27 EDTDNDN
theflyonthewall.com: Pre-market top 5 gainers
The following stocks were the top percentage gainers before the open on solid volume of at least 50,000 shares, trading at over $10. MDVN 19%, STX 14%, WHR 9.2%, FTNT 8.9%, DNDN 5%. :theflyonthewall.com
09:22 EDTDNDN
theflyonthewall.com: Dendreon's new CEO has a history of M&A, says Deutsche Bank
Deutsche Bank said Dendreon's new CEO, John Johnson, has a history of M&A and his fresh perspective might benefit the company's near-term strategy. The firm notes Johnson successfully sold Imclone to Eli Lilly (LLY) and attempted to sell Savient (SVNT). Shares are Buy rated with a $20 price target. :theflyonthewall.com
08:59 EDTDNDN
theflyonthewall.com: Dendreon volatility low as shares rally on succession plan

Subscribe for More Information :theflyonthewall.com
08:17 EDTDNDN
theflyonthewall.com: Dendreon jumps in pre-market trading, resistance at $14.98, then $15.88

Subscribe for More Information :theflyonthewall.com
06:56 EDTDNDN
theflyonthewall.com: Dendreon to host conference call
Conference call to discuss CEO and chairman succession plan will be held on February 1 at 9 am. Webcast Link :theflyonthewall.com
06:35 EDTDNDN
theflyonthewall.com: Dendreon announces CEO and chairman succession plan

Subscribe for More Information :theflyonthewall.com

January 25, 2012
10:29 EDTDNDN
theflyonthewall.com: On The Fly: Analyst Initiation Summary

Subscribe for More Information :theflyonthewall.com
06:53 EDTDNDN
theflyonthewall.com: Stocks with implied volatility movement; DNDN BA
Stocks with implied volatility movement; Dendreon (DNDN), Boeing (BA) according to iVolatility. :theflyonthewall.com

January 24, 2012
16:08 EDTDNDN
theflyonthewall.com: Dendreon initiated with a Hold at Cantor

Subscribe for More Information :theflyonthewall.com
11:44 EDTDNDN
theflyonthewall.com: Dendreon call calls active on renewed takeover chatter

Subscribe for More Information :theflyonthewall.com
11:28 EDTDNDN
theflyonthewall.com: Rumor: Dendreon spikes on renewed takeover chatter "again"

Subscribe for More Information :theflyonthewall.com

January 23, 2012
06:55 EDTDNDN
theflyonthewall.com: Stocks with implied volatility below IV index mean; CCL DNDN

Subscribe for More Information :theflyonthewall.com